Ferrer Group Inc. Company Profile

23:20 EST 25th January 2015 | BioPortfolio

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the fields of medicine and pharmacology, and maintain direct contact with health professionals, patients and the general public.

Location

Edifici L'illaDiagonal, 549 5a planta
Barcelona
E-08029
Spain

Contact

Phone: 34 93 600 37 00
Fax: 34 93 490 70 78
Email: medicaldepartment@ferrergrupo.com


News Articles [425 Associated News Articles listed on BioPortfolio]

Ferrer buys $8 million of Alexza shares, to eliminate certain Adasuve milestone payments

US drugmaker Alexza Pharmaceuticals and privately-held Spanish firm Grupo Ferrer Internacional have amended their agreement for the schizophrenia or bipolar disorder drug Adasuve (Staccato loxapine).

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for ozenoxacin 1% cream in Canada to local drugmaker Cipher Pharmaceuticals.

Ferrer licenses commercialisation rights for Ozenoxacin in Canada to Cipher Pharmaceuticals Inc.

Ozenoxacin, a novel bactericidal non-fluorinated quinolone, will complete a second phase III clinical trial in adult and paediatric patients with impetigo in the first quarter of 2015... The post Ferr...

Alexza, Ferrer deal

Cipher Pharmaceuticals acquires Canadian commercialization rights to Ozenoxacin

Mississauga, ON- Cipher Pharmaceuticals Inc. reports it is expanding its dermatology product portfolio licensing the Canadian rights to Ozenoxacin, a topical treatment for adult and paediatric patient...

Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-12-09. This 38-page rep...

BMG Pharma S.r.l Grants the Exclusive Distribution Rights for GelX® Oral Gel and GelX® Spray for the Treatment of Oral Mucositis in Cancer Patients to FERRER INTERNACIONAL S.A.

MILAN, January 19, 2015 /PRNewswire/ --   BMG Pharma S.r.l. (BMG) today is pleased to announce that it has signed an exclusive distribution agreement with FERRER INTERNACIONAL S.A. (Ferrer), gr...

Cipher acquires Canadian commercialization rights to new antibacterial compound Ozenoxacin

Cipher Pharmaceuticals announced that it has licensed the Canadian rights to Ozenoxacin, a topical treatment for adult and paediatric patients with impetigo, from Ferrer, a privately-held Spanish phar...

PubMed Articles [2427 Associated PubMed Articles listed on BioPortfolio]

Reduction of Campylobacter jejuni in Broiler Chicken by Successive Application of Group II and Group III Phages.

Bacteriophage treatment is a promising tool to reduce Campylobacter in chickens. Several studies have been published where group II or group III phages were successfully applied. However, these two gr...

Study About the Effects of Different Fitness Sports on Cognitive Function and Emotion of the Aged.

The aim of the study was to explore the effects of different fitness sports on cognitive function and emotion of the aged people. A total of 150 subjects aged between 60 and 70 were recruited from She...

The Attenuation of Lung Ischemia Reperfusion Injury by Oxymatrine.

To investigate the protective effects of oxymatrine (OMT) on lung ischemia reperfusion injury (LIRI) in rabbits, models of LIRI in rabbit were used. Thirty-two rabbits were randomly divided into four ...

The effect of preemptive perianal ropivacaine and ropivacaine with dexmedetomidine on pain after hemorrhoidectomy: a prospective, randomized, double-blind, placebo-controlled study.

The objective of this study was to assess the efficacy of perianal infiltration of ropivacaine and dexmedetomidine added to ropivacainein in the relief of pain after hemorrhoidectomy. Patients in grou...

The Effects of Within- and Between-Group Competition on Trust and Trustworthiness among Acquaintances.

Several studies have indicated that between-group competition is a key stimulator of trust and trustworthiness. Another important but neglected type of competition may also affect trust and trustworth...

Clinical Trials [1426 Associated Clinical Trials listed on BioPortfolio]

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Psychological Prevention of Internalizing Disorders

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...

Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -

The purpose of the study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the pati...

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

To compare the clinical efficacy of donepezil between the naive group and the switching group.

Companies [1443 Associated Companies listed on BioPortfolio]

Ferrer Group Inc.

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the...

Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. Since its founding i...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Ferrer Group Inc." on BioPortfolio

We have published hundreds of Ferrer Group Inc. news stories on BioPortfolio along with dozens of Ferrer Group Inc. Clinical Trials and PubMed Articles about Ferrer Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ferrer Group Inc. Companies in our database. You can also find out about relevant Ferrer Group Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record